GCGR and type 2 diabetes mellitus: In pre-clinical models of T1D and T2D, however, GCGR antagonism improves glycemia and readily promotes the regeneration of functional beta cell mass through, for example, beta cell proliferation and alpha-to-beta-cell transdifferentiation [[11], [12], [13], [14], [15], [16]].